|
| Thursday, October 29, 2015 |
|
|
A*STAR Findings on Breast Cancer Hold Potential for New Treatments |
| Scientists at the Bioinformatics Institute (BII) and Genome Institute of Singapore (GIS), research institutes under the Agency for Science, Technology and Research (A*STAR), have made discoveries that could lead to new ways of diagnosing and treating breast cancer. more info >> |
|
| Monday, September 21, 2015 |
|
|
A*STAR Scientists Reveal How Stem Cells Defend Against Viruses |
| Scientists from the Institute of Molecular and Cell Biology, a research institute under the Agency for Science, Technology and Research, Singapore, have uncovered the mechanisms which embryonic stem cells employ to inhibit virus expression. The ground-breaking discovery could potentially advance stem cell therapeutics and diagnostics. more info >> |
|
| Thursday, July 16, 2015 |
|
|
First Made-in-Singapore Cancer Drug Enters Clinical Testing |
| A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide. more info >> |
|
| Tuesday, July 14, 2015 |
|
|
Agilent Technologies and A*STAR's Bioprocessing Technology Institute Collaborate on New Bioanalytical Methodologies |
| Agilent Technologies Inc. (NYSE: A) and the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology and Research (A*STAR) today announced that they will collaborate on new analytical approaches to analyzing specific protein-linked sugar compounds. more info >> |
|
| Friday, May 29, 2015 |
|
|
Finding Loopholes in the Genome: First-of-its-Kind Predictive Tool to Identify Sequences Susceptible to Causing Mutations, Genome Instability and Diseases |
| Scientists from A*STAR's Bioinformatics Institute (BII) have developed an analytical model and computational tool to rapidly and accurately predict the occurrence and locations of R-loop Forming Sequences (RLFSs) in any genome or artificial nucleic acid sequences. more info >> |
|
| Wednesday, February 4, 2015 |
|
|
Infant Gut Microbiota Linked With Gestation Duration, Delivery Method and Healthy Weight Gain |
| Researchers in Singapore and UK as part of the EpiGen consortium worked together with scientists at the Nestle Research Center, Switzerland, on a new study on the bacterial makeup of the gut (gut microbiota) of infants in Singapore. more info >> |
|
| Friday, December 19, 2014 |
|
|
A*STAR Scientists Discover Gene Critical for Proper Brain Development |
| Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a genetic pathway that accounts for the extraordinary size of the human brain. more info >> |
|
| Wednesday, December 17, 2014 |
|
|
Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients |
| A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing drug resistance. more info >> |
|
| Monday, December 1, 2014 |
|
|
Singapore Scientists Uncover Gene Associated with an Aggressive Breast Cancer |
| Scientists at A*STAR's Genome Institute of Singapore (GIS), in collaboration with local clinicians and colleagues in the USA, have identified a biomarker which is strongly associated with triple negative breast cancer (TNBC), a highly aggressive carcinoma that often has early relapse and metastasis[1] following chemotherapy. more info >> |
|
| Wednesday, October 15, 2014 |
|
|
Fujitsu Partners with Singapore to Set Up Centre of Excellence for Sustainable Urbanization |
| Fujitsu Limited, the Agency for Science, Technology and Research (A*STAR) and the Singapore Management University (SMU) have today signed a Master Research Collaboration Agreement (MRCA) at Fusionopolis. more info >> |
|
|
|
